Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
ZT

ZTS

Market Closed

Zoetis Inc.

NYSEHealthcareDrug Manufacturers - Specialty & Generic
US
14.50K employees
CEO: Kristin C. Peck
Founded: 2013
$82.32
+$0.00(+NaN%)
Market Cap
34.02B
Beta
0.68
52W Range
N/A
Dividend Yield
2.58%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Zoetis Inc. displays significant undervaluation with a 91.6% implied upside and a robust fair value of $157.74 versus the current $82.32 price. Strong liquidity, profitability, and efficiency contrast with low leverage and moderate growth, while Monte Carlo scenarios indicate high volatility but limited downside risk (11.4%). Valuation consistency across multiple methods and high confidence suggest substantial long-term opportunity despite elevated price uncertainty.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore ZTS

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ZTS in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →